Psychiatric rating scales are commonly used in both research and clinical practice to facilitate patient evaluations for mental health. Scales are designed to meet various needs, including screening, diagnosis, and treatment monitoring. Explore our Psychiatric Scales NPsychlopedia for assessment tools you may be able to incorporate into your daily practice. The decision about which tool to use will vary and should be dictated by the setting you practice in, the age of your patient, and the instrument’s intended use.
This list is provided for educational purposes only. The scales described here are provided for your convenience. This is not an exhaustive list. AbbVie Inc. does not endorse or recommend the use of any specific scale. Healthcare providers should use their clinical judgment when reviewing educational resources on NP Psych Navigator.
Please note: While each category in the drop-down menu has been independently validated, the combinations across categories have not all been examined in the literature. Additional research may be needed in order to confirm whether a particular scale is appropriate for a particular patient population.
Antidepressant Treatment Response Questionnaire (ATRQ)
The Massachusetts General Hospital (MGH) Antidepressant Treatment Response Questionnaire (ATRQ) is a scale used to assess treatment response or nonresponse to adequate treatment trials among patients with major depressive disorder (MDD).1 The ATRQ examines the adequacy of duration and dose of prior and current antidepressant treatment trials.2 The ATRQ also assesses the degree of improvement in depressive symptoms in the most efficacious trial or in all trials during the current episode.2 The utility of this scale is in allowing a patient-report tool to take the place of a potentially lengthy clinician interview in assessing past antidepressant treatment adequacy and efficacy.1
Clinically Useful Depression Outcome Scale (CUDOS)
The Clinically Useful Depression Outcome Scale (CUDOS) is a brief, quickly scored, self-report scale used to assess depressive symptoms over the past 1 week. CUDOS is reliable, valid, and sensitive to change.1 The CUDOS consists of 18 questions. The first 16 are scored from 0 to 4 for frequency of symptoms over the past week. The final 2 questions cover the impact of these symptoms on the respondent’s life and their overall quality of life in the past week.2
DSM-5 Cultural Formulation Interview
The DSM-5 Cultural Formulation Interview (CFI) is a structured interview to help clinicians assess the impact of cultural features or other factors that might be relevant to a patient’s diagnosis or treatment.1,2 It was developed by the American Psychiatric Association’s DSM-5 Cross-Cultural Issues Subgroup.1
Epworth Sleepiness Scale (ESS)
The Epworth Sleepiness Scale (ESS) is used to assess daytime sleepiness in adults.1 The prevalence of daytime sleepiness in people with depressive symptoms is high—ranging from about 40%-50%.2 Clinicians can consider using the ESS to measure daytime sleepiness in patients experiencing depressive episodes. The ESS has demonstrated a positive association with depressive scores (e.g., on the Beck Depression Inventory) in people with Major Depressive Disorder (MDD).3
RMS (Rapid Mood Screener) Tool
The Rapid Mood Screener (RMS) is a novel, pragmatic, patient-reported tool to assess patients for bipolar I disorder.1 The RMS is a screening tool that was developed to help differentiate bipolar I disorder from major depressive disorder (MDD) in patients with depressive symptoms who have been diagnosed with MDD.1